Peng Yuan
Jiangsu University(CN)The University of Sydney(AU)Guangdong University of Technology(CN)Central South University(CN)University of Electronic Science and Technology of China(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Ningxia University(CN)Sichuan University(CN)Renji Hospital(CN)Peking Union Medical College Hospital(CN)Jianghan University(CN)Sichuan Agricultural University(CN)Wuhan City Chinese Medicine Hospital(CN)National Cancer Center(US)Hubei 672 Orthopedics Hospital of Traditional Chinese Medicine and Western Medicine(CN)First People's Hospital of Kunshan(CN)Wuhan No.1 Hospital(CN)Peking University People's Hospital(CN)Wuhan Union Hospital(CN)Wuxi People's Hospital(CN)Human Growth Foundation(US)Union Hospital(CN)Huazhong University of Science and Technology(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Lesions and Carcinomas
Most-Cited Works
- → IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor(2021)355 cited
- → Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning(2021)217 cited
- → RC48-ADC, a HER2-targeting antibody-drug conjugate, in patients with HER2-positive and HER2-low expressing advanced or metastatic breast cancer: A pooled analysis of two studies.(2021)102 cited
- → Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM(2016)95 cited
- → Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial(2016)95 cited
- →